GDF-15 can predict heart failure risk, especially in diabetes patients: Study
USA: Growth differentiation factor-15 (GDF-15) provides complementary prognostic information on the risk of heart failure (HF), particularly among people with diabetes, says a recent study in Diabetologia. The researchers however add that it is not clear to which extent GDF-15 is associated with HF among people with and without diabetes.
Elevated circulating growth differentiation factor-15, a marker of cellular stress, is shown to be associated with both diabetes and heart failure. However, to what extent GDF-15 is associated with HF among individuals with and without diabetes is not clear.
Justin B. Echouffo-Tcheugui, Johns Hopkins University School of Medicine, Baltimore, MD, USA, and colleagues evaluated 10,570 participants free of HF at Visit 3 (1993–1995) of the Atherosclerosis Risk in Communities study.
The researchers used Cox regression for evaluating the joint associations of GDF-15 and diabetes with incident HF. Adjustment of models was sone for traditional cardiovascular risk factors.
Salient findings of the study include:
- Among a total of 10,570 individuals (mean age of 60.0 years, 54% women, 27% black adults), elevated GDF-15 (≥75th percentile) was more common in people with diabetes compared with those without diabetes (32.8% vs 23.6%).
- During 23 years of follow-up, there were 2429 incident HF events.
- GDF-15 (in quartiles) was independently associated with HF among those with and without diabetes, with a stronger association among individuals with diabetes: HR for the highest vs lowest GDF-15 quartile (reference): 1.64 among those without diabetes and 1.72 among those with diabetes.
- Individuals with diabetes and elevated GDF-15 had the highest risk of incident HF (HR 2.46).
- After accounting for HF risk factors, GDF-15 provided additional prognostic information among participants with diabetes (ΔC statistic for model with vs model without GDF-15: +0.008) and among those without diabetes (+0.006).
"GDF-15 provided complementary prognostic information on the HF risk, especially among individuals with diabetes in a community-based sample of US adults," the authors concluded.
Reference:
Echouffo-Tcheugui, J.B., Daya, N., Ndumele, C.E. et al. Diabetes, GDF-15 and incident heart failure: the atherosclerosis risk in communities study. Diabetologia 65, 955–963 (2022). https://doi.org/10.1007/s00125-022-05678-6
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.